Financial Year End | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
---|---|---|---|---|---|
Revenue | 2.06T | 2.27T | 2.58T | 886.76B | N/A |
Cost of Revenue | 546.76B | 595.39B | 695.18B | 222.19B | N/A |
Gross Profit | 1.51T | 1.68T | 1.89T | 664.58B | N/A |
Operating Expenses | 1.64T | 1.70T | 1.81T | 564.73B | 7.60B |
Selling, General & Admin | 655.67B | 704.53B | 745.70B | 227.12B | N/A |
Research & Development | N/A | N/A | N/A | N/A | N/A |
Other Operating Expenses | 981.74B | N/A | N/A | N/A | 7.60B |
Operating Income | -125.06B | -918.47B | -16.91B | 59.67B | -7.60B |
Other Expenses / Income | -462.88B | 195.55B | 279.31B | -50.42B | -11.33B |
Before Tax Income | -587.94B | -722.91B | 262.40B | 9.25B | N/A |
Income Tax Expenses | -338.26B | -82.54B | 202.10B | 24.26B | N/A |
Net Income | -257.73B | -647.21B | 52.56B | -16.80B | N/A |
Interest Expenses | -94.87B | 46.56B | 103.21B | 46.51B | 10.63B |
Basic Shares Outstanding | 2.15B | 430.74M | 430.74M | 430.74M | 430.74M |
Diluted Shares Outstanding | 2.15B | 430.74M | 430.74M | 430.74M | 430.74M |
EBITDA | 175.33B | 31.53B | 1.18T | 297.50B | 163.88B |
EBITDA Margin | 8.51% | 1.39% | 45.72% | 33.55% | 0.00% |
EBIT | -690.86B | -683.18B | 357.88B | 53.96B | 10.63B |
EBIT Margin | -33.55% | -30.09% | 13.87% | 6.09% | 0.00% |
Financial Year End | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |